The branch aims to support growing business activities in China.
Lipid ingredients specialist Enzymotec (Migdal HaEmeq, Israel) has opened an office in Shanghai-a branch the company says aims to support growing business activities in China. The company has a presence in more than 40 countries.
“Southeast Asia in general, and China in particular, have become key markets for us due to the economic developments in the region,” said Enzymotec CEO Ariel Katz, PhD, in a press statement.
Enzymotec develops and manufactures lipid-based nutraceutical ingredients. Its business is divided in three segments: infant nutrition (with InFat, a clinically proven ingredient that mimics the fat of human milk and is marketed through Advanced Lipids AB, a joint venture of AAK and Enzymotec); bioactives; and pharmaceutical.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
Enhance Collagen Joint Health: Boost Flexibility, Mobility & Cartilage Support – Infographic
March 25th 2025Four gold standard clinical studies have demonstrated AprèsFlex® efficacy starting at five days — with a low dose, both rapid and sustained improvements in joint comfort, stiffness, flexibility and physical function were observed.